AzTrials
AzTrials

Sars-CoV2NCT04475068

Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection

An observational study of Sars-CoV2 and ARDS, run by Hospital Nacional Edgardo Rebagliati Martins at 1 site in Peru.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate if a postural recruitment maneuver (PRM) improves the aeration and distribution of lung ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection; without the need to reach high airway pressures as in the standard lung recruitment… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sars-CoV2, ARDS
What is being tested?
Lateral Position (left and right lateral decubitus)
Type of treatment
Surgery or procedure
How many people
15 participants
Where
1 sitePeru
Study dates
17 Jul 2020to 31 Oct 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This physiological study will enroll 12 adult ARDS patients admitted to the COVID Intensive Care Unit of Rebagliati Hospital. Informed consent will be obtained from the patient or legally authorized substitute decision maker.

Who may be able to join

  • Patients > 18 years of age
  • Patients with moderate-to-severe ARDS as per the Berlin definition
  • Infection due to COVID-19
  • Body mass index (BMI) ≤ 35 kg /m^2.

Who cannot join

  • Contraindication for EIT monitoring
  • Unstable spine or pelvic fractures
  • Pacemaker, automatic implantable cardioverter defibrillator
  • Skin lesions between the 4th and 5th ribs where the EIT belt is worn
  • Pregnancy
  • Major hemodynamic instability::
Show all 11Show fewer
  • Mean arterial pressure lower than 60 mm Hg despite adequate fluid resuscitation and use of vasopressors.
  • FC> 120 or <60 per minute
  • Presence of uncontrolled arrhythmias.
  • More than 1 week of mechanical ventilation
  • Failure of more than 2 extrapulmonary organs.

Trial locations and contacts

1 site in 1 country.

Peru1 site
  • Hospital Rebagliati

    Jesús María, Lima, Lima 11

Other trials in Peru

About this study

Official title: Feasibility and Physiological Effects of a Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection

The purpose of this study is to evaluate if a postural recruitment maneuver (PRM) improves the aeration and distribution of lung ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection; without the need to reach high airway pressures as in the standard lung recruitment maneuver and / or place the patient in prone position. This strategy could be particularly useful in the context of a major health emergency in centers with limited resources.

Read the detailed description

The PRM is based on the known effect of gravity on transpulmonary pressure (PL). Two principles explain its mechanism of action: 1) the first indicates that atelectasis and poorly ventilated areas of the lung can improve their aeration by putting the lung in the highest position. Opposite lateral decubitus causes that upper lung to have a higher PL and allow a recruiting effect at moderate airway pressures. 2) The second principle is based on Laplace's Law and postulates that once the upper lung is recruited, it remains without lung collapse if a sufficient level of positive end-expiratory pressure (PEEP) is applied. Based on these two precepts, PRM consists of sequentially moving the patient from the supine to the left lateral decubitus to recover the aeration of the right lung. After that, the patient is placed in the right lateral position to recruit the left lung; keeping the right lung without collapse by continuous use of PEEP. Finally, the patient returns to the supine position looking for an improvement in the distribution of ventilation and global pulmonary aeration, with a subsequent improvement in gas exchange and pulmonary mechanics.

Conditions
Sars-CoV2, ARDS
Being tested
Lateral Position (left and right lateral decubitus)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lateral Position (left and right lateral decubitus)Procedure or surgery

    Prior to initiating the protocol, patients will be sedated deeply with sedatives and opioids and paralyzed. Patients will be evaluated in 5 positions sequentially: 1) Supine 2) Left lateral 3) Supine 4) Right lateral 5) Supine. The side with the least ventilation evaluated by EIT will define which side will start the sequence. Each step will last 30 minutes. Aeration measured by Electric Impedance Tomography (EIT) and lung ultrasound, distribution of the lung ventilation and perfusion measured by EIT, ventilator and hemodynamic parameters, esophageal pressure, and blood gas analysis will be recorded at the end of each step. Continuous monitoring of blood pressure, heart rate and saturation of arterial blood (SpO2) will be carried out during all steps of the protocol to assess the tolerance to the procedure.

Study groups in NCT04475068
Study groupRoleWhat they receive
Moderate to severe ARDS patients due to COVID-19 infectionMechanically ventilated patients with moderate to severe ARDS due to COVID-19 infection admitted to the COVID Intensive Care Unit of Rebagliati Hospital.
Receives: Procedure: Lateral Position (left and right lateral decubitus)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effects of a postural recruitment maneuver in lung aeration

    Lung aeration measured by ultrasound reaeration score, ranges from 0 (all regions are well aerated) to 36 (all regions are consolidated).

    Measured: Through study completion (up to 24 hours)

  2. Effects of a postural recruitment maneuver in distribution of ventilation

    Distribution of ventilation measured by EIT (distribution and changes in the impedance in AU, arbitray units)

    Measured: Through study completion (up to 24 hours)

  3. Effects of a postural recruitment maneuver in gas exchange

    Gas exchange measured by blood gas analysis (PaO2, PaCO2, in mmHg) and capnography (end-tidal CO2, in mmHg)

    Measured: Through study completion (up to 24 hours)

  4. Effects of a postural recruitment maneuver in respiratory mechanics

    Respiratory mechanics measured by esophageal balloon (esophageal pressure, transpulmonary pressure, in cmH2O)

    Measured: Through study completion (up to 24 hours)

  5. Effects of a postural recruitment maneuver in hemodynamic

    Hemodynamic data measured by invasive arterial monitoring (mean arterial pressure, in mmHg)

    Measured: Through study completion (up to 24 hours)

Secondary outcomes (1)
  1. Feasibility of a postural recruitment maneuver

    Oxigenatory tolerance evaluated with pulse oximeter (arterial oxygen saturation, in percentage)

    Measured: Through study completion (up to 24 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2020
  2. Study start17 Jul 2020
  3. Primary completion30 Sep 2020
  4. Study completion31 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04475068
Sponsor's protocol ID
HNEdgardoRebagliatiMartins
Status last verified
Aug 2021
First submitted
14 Jul 2020
Last updated
25 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Roldan R, Rodriguez S, Barriga F, Tucci M, Victor M, Alcala G, Villamonte R, Suarez-Sipmann F, Amato M, Brochard L, Tusman G. Sequential lateral positioning as a new lung recruitment maneuver: an exploratory study in early mechanically ventilated Covid-19 ARDS patients. Ann Intensive Care. 2022 Feb 12;12(1):13. doi: 10.1186/s13613-022-00988-9.

    PubMed 35150355

Questions about this trial

What is this clinical trial studying?

An observational study of Sars-CoV2 and ARDS, run by Hospital Nacional Edgardo Rebagliati Martins at 1 site in Peru.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Peru. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effects of a postural recruitment maneuver in lung aeration (time frame: Through study completion (up to 24 hours)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04475068, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in